It is a dataset composed by data from November 2023 and August 2024, when 1,719 samples were analyzed, of which 189 and 191 were positive for dengue and chikungunya, respectively.
* This trial included adult patients (18–65 years old) with a typical presentation of acute chikungunya disease (defined by acute febrile arthralgia) diagnosed within less than 48 ho
